European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ. Alfred Witjes, Antoine G. van der Heijden, Matthew I. Milowsky et al.|European Urology|2023Cited by 618
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G. van der Heijden, Michael Rink, Harman Max Bruins et al.|European Urology|2025Cited by 159
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Ken Herrmann, Alberto Bossi et al.|European Journal of Cancer|2023Cited by 156
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T. Miyamoto, Daniel A. Haber, Richard J. Lee et al.|Cancer Discovery|2018Cited by 140
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCsHongshan Guo, Daniel A. Haber, Joanna Vuille et al.|Cell|2023Cited by 70